Ubrelvy shortage?

Short answer: shortages for Ubrelvy (ubrogepant) can happen and are usually regional and time-limited. I can’t check live inventory, but here are ways to verify and what to do.

What to check
- In the US: FDA Drug Shortages list (druginfo.nlm.nih.gov) and search for ubrogepant or Ubrelvy. Also check Lilly’s Ubrelvy patient information page for any notices.
- Call or visit your local pharmacy and ask:
- Is Ubrelvy in stock or on backorder?
- Can they check other nearby pharmacies or set up an alert when it’s back in stock?
- Is a different strength or a second source available?
- Talk to your prescriber or pharmacist about alternatives if Ubrelvy isn’t available.

What to do if you can’t get Ubrelvy right now
- Consider alternatives for acute migraine treatment after discussing with your clinician:
- Nurtec ODT (rimegepant) is another CGRP receptor antagonist for acute treatment.
- Triptans (e.g., sumatriptan, rizatriptan) or NSAIDs are common alternatives, depending on your medical history and contraindications.
- Your clinician can advise on the best option for you and whether any dose adjustments are needed.

Important dosing note (for reference)
- Ubrelvy is taken as a 50 mg or 100 mg tablet, with a possible second dose after at least 2 hours if needed, not to exceed 200 mg in 24 hours. Do not exceed prescribed dosing.

If you’d like, tell me your country or region and I can try to point you to the current official shortage status for Ubrelvy there, or help you think through the best next steps with your healthcare provider.